Correlation of circulating tumor cells (CTCs) expressing stemness and EMT phenotypes with immunosuppressive cells in metastatic breast cancer patients

被引:2
|
作者
Aggouraki, Despoina [1 ]
Papadaki, Maria [1 ]
Vetsika, Eleni Kyriaki [1 ]
Koutoulaki, Anna [1 ]
Kotsakis, Athanasios [2 ]
Kallergi, Galatea [1 ]
Agelaki, Sofia [2 ]
Mavroudis, Dimitris [2 ]
Georgoulias, Vassilis [2 ]
机构
[1] Univ Crete, Sch Med, Lab Canc Cell Biol, Iraklion, Greece
[2] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
关键词
D O I
10.1158/1538-7445.AM2014-3030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3030
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib
    Kalykaki, Antonia
    Agelaki, Sofia
    Kallergi, Galatea
    Xyrafas, Alexandros
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 685 - 693
  • [32] Correlation of changes in circulating tumor cells and radiographic response to treatment in patients with metastatic breast cancer
    Budd, GT
    Cristofanilli, M
    Terstappen, LW
    Ellis, MJ
    Stopeck, A
    Allard, WJ
    Matera, J
    Miller, MC
    Doyle, GV
    Hayes, DF
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S226 - S226
  • [33] Phenotypic characterization of circulating tumor cells (CTCs) in triple negative breast cancer patients
    Kallergi, Galatea
    Markomanoiaki, Haris
    Mavroudis, Dimitrios
    Georgoulias, Vassills
    Agelaki, Sofia
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [34] Circulating tumor cells (CTCs) in peripheral blood of primary breast cancer patients.
    Rack, B. K.
    Schindlbeck, C.
    Janni, W. J.
    Hofmann, S.
    Jeschke, U.
    Thurner-Hermanns, E.
    Hilfrich, J.
    Beckmann, M. W.
    Pantel, K.
    Lichtenegger, W.
    Sommer, H.
    Friese, K.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S215 - S215
  • [35] Phenotypic characterization of circulating tumor cells (CTCs) in triple negative breast cancer patients
    Kallergi, G.
    Agelaki, S.
    Mathioudaki, A.
    Mavroudis, D.
    Georgoulias, V.
    [J]. EJC SUPPLEMENTS, 2010, 8 (07): : 156 - 156
  • [36] Circulating tumor cells (CTCs) biomarker evaluation from patients with metastatic breast cancer (MBC) utilizing the TargetSelector™ platform
    Hamilton, E. P.
    Yardley, D. A.
    Burris, H. A., III
    Shastry, M.
    Huynh, L.
    Bhikha, L.
    Singh, V. M.
    [J]. CANCER RESEARCH, 2017, 77
  • [37] Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment
    Green, Taryn L.
    Cruse, Julius M.
    Lewis, Robert E.
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 95 (02) : 174 - 179
  • [38] Genome-Wide Copy Number Analysis of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients
    Magbanua, M. J. M.
    Sosa, E. V.
    Scott, J. H.
    Pinkel, D.
    Rugo, H. S.
    Park, J. W.
    [J]. CANCER RESEARCH, 2010, 70
  • [39] Characteristics of circulating tumor cells (CTCs) in patients with lung cancer
    Vlajnic, T.
    Brady, L.
    Casey, O.
    Gately, K.
    Barr, M. P.
    Cuffe, S.
    Bubendorf, L.
    Finn, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S66 - S66
  • [40] Circulating tumor cells (CTCs) in breast cancer without distant metastases
    Gabaraeva, Vera
    Kit, Oleg Ivanovich
    Novikova, Inna Arnoldovna
    Nikipelova, Elena Alekseevna
    Shatova, Yuliana Sergeyevna
    Bakhtin, Andrey Vladimirovich
    Chernikova, Elena N.
    Komova, Elizaveta A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)